INTRODUCTION TO TREATMENT SOLUTIONS FOR OVERACTIVE BLADDER SYNDROME AND LOWER URINARY TRACT SYMPTOMS CAUSED BY BENIGN PROSTATIC HYPERTROPHY
Committed to continuously supporting healthcare professionals in staying up-to-date with the latest treatment advancements, Medbolide Pharmaceutical JSC successfully organized a scientific seminar to introduce the product Lozatex (Flavoxate hydrochloride 100 mg) at Chanh Hung General Hospital.
The program provides an opportunity for doctors and healthcare professionals to exchange specialized knowledge about Flavoxate hydrochloride, while also updating their understanding of the active ingredient’s role in treating overactive bladder (OAB) and helping to alleviate lower urinary tract symptoms (Lower Urinary Tract Symptoms – LUTS) associated with benign prostatic hyperplasia (BPH).

FLAVOXATE HYDROCHLORIDE – AN ACTIVE INGREDIENT THAT HELPS RELIEVE URINARY TRACT SPASMS
Flavoxate hydrochloride is an active ingredient that relaxes the smooth muscles of the urinary tract, helping to reduce abnormal bladder spasms. Through this mechanism, Flavoxate helps improve many symptoms that affect patients’ quality of life, such as:
- Urgency to urinate.
- Frequent urination.
- Nocturia.
- A constant urge to urinate.
- Pain or discomfort during bladder contractions.
In clinical practice, Flavoxat is used to help manage symptoms of urinary tract irritation in various patient groups, particularly those with overactive bladder syndrome or urinary disorders related to prostate conditions.
THE ROLE OF FLAVOXAT IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Benign prostatic hyperplasia is a common condition among middle-aged and elderly men. In addition to symptoms of urinary obstruction, many patients also experience irritative symptoms such as urinary urgency, frequent urination, and nocturia, which significantly reduce their quality of life.
During the presentation, the doctors discussed the role of Flavoxat in helping to alleviate this group of irritative symptoms. When used appropriately as prescribed by a doctor, the active ingredient can help patients:
- Reduce the sensation of sudden urgency to urinate.
- Limit the number of times they urinate during the day and at night.
- Alleviate discomfort caused by bladder spasms.
- Improve quality of life and comfort in daily activities.
These updates garnered the attention of the attending physicians due to their high practical applicability in clinical practice.

LOZATEX – MEDBOLIDE’S 100 MG FLAVOXATE HYDROCHLORIDE PRODUCT
Lozatex is a product containing 100 mg of flavoxate hydrochloride, developed by Medbolide to address the treatment of bladder dysfunction and symptoms of urinary tract irritation, as prescribed by a doctor.
Through the scientific presentation, Medbolide provided updates on the pharmacological properties of the active ingredient, its indications, target patient population, and important considerations for clinical practice. The event also provided an opportunity for physicians to exchange treatment experiences, share clinical cases, and discuss common challenges encountered in patient care.
The open atmosphere of discussion, combined with practical perspectives, provided significant professional value to the participating healthcare professionals.
MEDBOLIDE IS COMMITTED TO SUPPORTING THE HEALTHCARE COMMUNITY
For many years, Medbolide has been dedicated to developing training programs and providing updates on medical knowledge for doctors, pharmacists, and healthcare workers at hospitals and clinics across the country.
The Lozatex product presentation at Chanh Hung General Hospital further reaffirmed Medbolide’s commitment to providing scientific, accurate, and practically valuable information, thereby helping to improve treatment outcomes and the quality of patient care.
In the coming period, Medbolide will continue to collaborate with healthcare facilities to organize professional training activities and introduce evidence-based treatment solutions, partnering with healthcare professionals on their journey to improve public health.